Publications by authors named "Gema Barkanic"

Claim this Profile
D
Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts.
Catherine C McGowan, David D Weinstein, Charles P Samenow, Samuel E Stinnette, Gema Barkanic

PLoS One· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.
Vlada V Melekhin, Bryan E Shepherd, Samuel E Stinnette, Peter F Rebeiro, Gema Barkanic

PLoS One· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Jennifer H Tai, Mercy A Udoji, Gema Barkanic, Daniel W Byrne, Peter F Rebeiro

J Infect Dis· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
Todd Hulgan, Bryan E Shepherd, Stephen P Raffanti, Jennifer S Fusco, Robin Beckerman, Gema Barkanic

J Infect Dis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
Todd Hulgan, Stephen Raffanti, Asghar Kheshti, Robert B Blackwell, Peter F Rebeiro, Gema Barkanic

J Infect Dis· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis